相关实验视频

Updated: Jun 7, 2025

Studying Triple Negative Breast Cancer Using Orthotopic Breast Cancer Model

Studying Triple Negative Breast Cancer Using Orthotopic Breast Cancer Model

Published on: March 20, 2020

低基质乳腺癌:通过重新定义第四阶段疾病来寻求治愈?

Dionysia N Zouki¹, Eleni A Karatrasoglou², Georgios Pilichos³

¹Breast Unit, University College London Hospitals NHS Foundation Trust, London, UK. dzouki@med.uoa.gr.

Current treatment options in oncology

|November 14, 2024

概括

低甲状腺性乳腺癌 (OMBC) 呈现一种中间疾病状态,通过焦点治疗有可能治愈. 本综述概述了当前的管理策略,并强调了治疗OMBC的未满足需求.

科学领域:

在瘤学瘤学.
癌症研究癌症研究
临床医学临床医学

背景情况:

乳腺癌是全球领先的恶性瘤,在早期阶段与转移性疾病之间有着不同的治疗目标.
基转移描述了局部癌症和广泛癌症之间的中间状态,可能适应治愈意图的焦点疗法.
由于有限的数据,对小卵性乳腺癌 (OMBC) 的管理仍然是一个重大未满足的需求.

研究的目的:

根据受影响的器官,审查有关OMBC管理的最新数据.
为OMBC当前的治疗模式建立一个框架.
突出OMBC临床实践中的挑战和正在进行的辩论.

主要方法:

对OMBC当前治疗策略的文献综述.
对寡头转移性疾病的特定器官管理方法的分析.
讨论多学科考虑和临床挑战.

主要成果:

局部根除疗法,如手术,放射治疗和切除,显示出对OMBC的长期结果的希望.
介绍了当前的治疗模式,以适应转移性传播所涉及的特定器官.
确定了关于OMBC管理的有争议的问题和临床担忧.

结论:

焦点治疗有可能在选择的OMBC患者中产生长期结果.
多学科的方法对于解决OMBC的复杂性至关重要.
需要进一步的研究和数据来优化这种独特的临床实体的管理.

关键词:

乳腺癌是什么? 乳腺癌是什么有治疗潜力的治疗潜力.当地根除疗法当地根除疗法有氧基质扩散症 (Oligometastasis)

更多相关视频

Treatment of Liver Metastases Using an Internal Target Volume Method for Stereotactic Body Radiotherapy

Treatment of Liver Metastases Using an Internal Target Volume Method for Stereotactic Body Radiotherapy

Published on: May 8, 2018

In Vivo Imaging to Measure Spontaneous Lung Metastasis of Orthotopically-injected Breast Tumor Cells

In Vivo Imaging to Measure Spontaneous Lung Metastasis of Orthotopically-injected Breast Tumor Cells

Published on: June 23, 2022

相关概念视频

Metastasis

Metastasis

Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...

Targeted Cancer Therapies

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...